Waterstone Hanxbio Pty Ltd
1 clinical trials · Sponsor
◉ Watch Waterstone Hanxbio Pty Ltd
| Record | Firm | Date |
|---|---|---|
| The Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced Malignancies (NCT04097769) | Waterstone Hanxbio Pty Ltd | 2019-06-12 |
Track Waterstone Hanxbio Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.